Skip to main content
logo
MedCap AB (publ) (STO:MCAP)
Sweden flag Sweden · Delayed Price · Currency is SEK
561.00
+9.50 (1.72%)
Nov 4, 2026, 5:29 PM CET

Revenue by Geography

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2017FY 2016
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Apr '17 Apr '16
Sweden Revenue
1.01B957.30M898.40M
Nordic (ex-Sweden) Revenue
671.50M612.50M448.60M
Europe (ex-Nordic) Revenue
589.10M484.60M384.70M
Rest of the World Revenue
49.00M53.70M75.10M
Revenue (Other)
-100.00K-100.00K-100.00K
Revenue (Total)
2.32B2.11B1.81B

Revenue Breakdown

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2017FY 2016
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Apr '17 Apr '16
Assistive Tech Revenue
1.07B981.80M767.20M
Medtech Revenue (Post-Q2 2023 Reporting)
752.30M689.60M607.70M
Medtech Revenue (Pre-Q3 2023 Reporting)
1.82B1.67B1.37B
Specialty Pharma Revenue
498.90M436.60M431.80M
Revenue (Other)
-1.82B-1.67B-1.37B
Revenue (Total)
2.32B2.11B1.81B

Revenue Breakdown 2

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2017FY 2016
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Apr '17 Apr '16
Pharmaceuticals Revenue
484.20M424.80M420.50M
Assistive Technology Revenue
1.07B981.30M765.90M
Medical Devices Revenue
333.40M320.10M322.70M
Nutrition & Other Food Revenue
379.00M333.60M251.80M
Other Product Revenue
55.20M48.20M45.90M
Revenue (Total)
2.32B2.11B1.81B

Adjusted EBITDA

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2017FY 2016
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Apr '17 Apr '16
Assistive Tech Adjusted EBITDA
331.00M289.50M212.00M
Medtech Adjusted EBITDA (Post-Q2 2023 Reporting)
173.00M145.90M138.30M
Medtech Adjusted EBITDA (Pre-Q3 2023 Reporting)
504.00M435.40M350.30M
Specialty Pharma Adjusted EBITDA
113.90M45.70M59.20M
Other and Eliminations from Adjusted EBITDA
-29.60M-24.80M-21.70M
Operating Income (Other)
-187.20M-153.40M-115.50M
Operating Income (Total)
401.10M302.90M272.30M

EBIT

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2017FY 2016
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Apr '17 Apr '16
Assistive Tech Operating Profit
249.10M217.30M164.10M
Medtech Operating Profit (Post-Q2 2023 Reporting)
130.10M103.20M98.70M
Medtech Operating Profit (Pre-Q3 2023 Reporting)
379.20M320.50M262.80M
Specialty Pharma Operating Profit
54.10M9.20M33.40M
Other and Eliminations from Operating Profit
-32.30M-26.80M-23.90M
Operating Income (Other)
100.00K--
Operating Income (Total)
401.10M302.90M272.30M